Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 6/20 | 0.77 |
| ▸ | CYP11B1 | P15538 | 5/20 | 0.77 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.68 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.65 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.65 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | PLAU | P00749 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.55 |
| ▸ | BCR | P11274 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22402247 | 1.00 | CYP11B2 (0.77) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL5980264 | 0.96 | CYP11B2 (0.73) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| Methyl Alcohol SCHEMBL29235275 | 0.96 | CYP11B2 (0.73) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL23747205 | 0.96 | CYP11B2 (0.78) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL27945362 | 0.96 | CYP11B2 (0.73) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL25041887 | 0.89 | CYP1A2 (0.83) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL3020390 | 0.89 | HSD17B1 (0.76) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL11723032 | 0.89 | HSD17B1 (0.83) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL12051687 | 0.89 | HSD17B1 (0.83) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL29588373 | 0.88 | CYP1A2 (0.79) | CYP11B2CYP11B1HSD17B1HSD17B2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303601-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
| CN-114591128-B | Direct cross-coupling method of aryl sulfide salt and aryl bromide | 南京工业大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-114685251-B | Direct cross-coupling reaction method of diaryl sulfoxide and aryl bromide | 南京工业大学 | 2022-12-27 | — | — | CN | disclosed |
| CN-114685251-A | Direct cross-coupling reaction method of diaryl sulfoxide and aryl bromide | 南京工业大学 | 2022-07-01 | — | — | CN | disclosed |
| CN-114591128-A | Direct cross-coupling method of aryl sulfur salt and aryl bromide | 南京工业大学 | 2022-06-07 | — | — | CN | disclosed |
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
| CN-104650110-B | Novel heterocyclic compound, method for producing intermediate therefor, and use thereof | 日本化药株式会社 | 2017-04-12 | — | — | CN | disclosed |
| CN-103391942-A | Novel heterocyclic compound, method for producing intermediate thereof, and use thereof | UNIV HIROSHIMA | 2013-11-13 | — | — | CN | disclosed |
| US-8470208-B2 | Organometallic complexes | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-25 | — | — | US | disclosed |
| US-8470208-B2 | Organometallic complexes | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-25 | — | — | US | disclosed |
| US-20090159130-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-25 | — | — | US | disclosed |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | GRACEL DISPLAY INC. (KR) | 2009-06-11 | — | — | US | disclosed |
| US-20090078317-A1 | Organometalic compounds for electroluminescence and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-03-26 | — | — | US | disclosed |
| US-7067524-B2 | Substituted phenyl naphthalenes as estrogenic agents | WYETH (US) | 2006-06-27 | — | — | US | disclosed |
| CN-1738788-A | Substituted phenylnaphthalenes as estrogenic agents | WYETH CORP (US) | 2006-02-22 | — | — | CN | disclosed |
| US-6914074-B2 | Substituted phenyl naphthalenes as estrogenic agents | WYETH (US) | 2005-07-05 | — | — | US | disclosed |
| US-20040225123-A1 | Substituted phenyl naphthalenes as estrogenic agents | MEWSHAW RICHARD E (US) | 2004-11-11 | — | — | US | disclosed |
| EP-1453782-A2 | SUBSTITUTED PHENYL NAPHTHALENES AS ESTROGENIC AGENTS | Wyeth (US) | 2004-09-08 | — | — | EP | disclosed |
| US-20030181519-A1 | Substituted phenyl naphthalenes as estrogenic agents | WYETH | 2003-09-25 | — | — | US | disclosed |
| WO-2003051805-A2 | SUBSTITUTED PHENYL NAPHTHALENES AS ESTROGENIC AGENTS | WYETH (US) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181519-A1 | Substituted phenyl naphthalenes as estrogenic agents | ESR2, ESR1, ESRRA | CYP11B2 257/4885CYP11B1 174/4885HSD17B1 160/4885 |
| US-20230303601-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | MGLL, SELENOI, APOL1 | CYP11B2 3840/4885CYP11B1 3748/4885HSD17B1 3449/4885 |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | LEF1, ODC1, AOC2 | CYP11B2 2615/4885CYP11B1 2065/4885HSD17B1 2583/4885 |
| US-20090078317-A1 | Organometalic compounds for electroluminescence and organic electroluminescent device using the same | OCIAD1, L1CAM, OCIAD2 | CYP11B2 1643/4885CYP11B1 1367/4885HSD17B1 2499/4885 |
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | CYP11B2 4666/4885CYP11B1 4354/4885HSD17B1 1285/4885 |
| US-20090159130-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | AOX1, LEF1, ODC1 | CYP11B2 731/4885CYP11B1 548/4885HSD17B1 1517/4885 |
| US-20040225123-A1 | Substituted phenyl naphthalenes as estrogenic agents | ESR2, ESR1, ESRRA | CYP11B2 257/4885CYP11B1 174/4885HSD17B1 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.